–
Neuroendocrine Cancer UK is thrilled to announce an upcoming Webi-Natter event focused on the recent news of NICE’s approval of SIRT Therapy for neuroendocrine tumours. Scheduled for May 30th from 6:00pm to 7:30pm (GMT), this event will delve into the implications of this approval for patients and the wider community.
Experts in the field, including Professor Rohini Sharma, Dr. Raj Srirajaskanthan, and patient panel member Leanne Armstrong, will shed light on the significance and practical applications of SIRT Therapy.
Participants can anticipate insightful presentations followed by an interactive Q&A session, providing an opportunity to address queries directly to the speakers. For those unable to attend live, the event will be recorded for later viewing.
Registration is now open, and attendees will receive a confirmation email containing the event link upon registration. Stay informed, engaged, and empowered with the latest developments in neuroendocrine cancer treatment. Join us for this enlightening Webi-Natter event!
REGISTER HERE: https://www.neuroendocrinecancer.org.uk/events/webi-natter-sirt-therapy-for-neuroendocrine-tumours/